RESERVE NOW
Vaccine
Gardasil 9
Indication
Age 9 or above
Usage
Reduce 90% of cervical cancer, 90-95% of anal cancer and their precancerous growth
Manufacturer
MSD
HK Registration Number
HK-64239
Registration
HK registration since 2015
Price
HK$1800
Dosage & Schedule

Age 9-14: 2 doses series on a 0-,6-month schedule

Age 15 or over: 3 doses series on a 0-,2-,6-month schedule

Peak Incidence Age
Age 26-30, and Age 46-55
Characteristics
  • Provide extra 85-90% of protection against Vaginal and Cervical cancer when compare to other HPV vaccine.
High Risk Groups
Recurrent HPV infection, Immunodeficient individual, Smoker
Common Side Effects
Mild redness and swelling at injection site. Occasionally, fever or headache might occur
Contraindication
  • Hypersensitivity, including severe allergic reactions to yeast (a vaccine component), or after a previous dose of GARDASIL 9 or GARDASIL
  • Pregnant women
  • Those with fever or suffering from moderate to severe illness
Vaccine
Bexsero
Indication
2 months old onwards
Usage
Prevent invasive meningococcal disease by Neisseria meningitidis B
Manufacturer
GSK
HK Registration Number
HK-66268
Registration
HK registration since 2019
Price
HK$1800
Dosage & Schedule

2 months old : 4 doses, at least 1 month between each dose

3-23 months old : 3 doses, at least 2 months between each dose

2 years old and above : 2 doses, at least 1 month apart

Peak Incidence Age
Aged below 1, and 16-23
Characteristics
  • The only Meningococcal B vaccine indicated for paediatric patients
  • Though Hong Kong has a low meningococcal infection rate, vaccination is still recommended for high-risk group
High Risk Groups
Immunodeficient individual, borders in dormitorie, students planning for overseas studies and travellers to high-risk countries
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), unusual crying, irritability, loss of appetite, vomiting, diarrhea, somnolence and rash
Contraindication
  • Severe allergic reaction to any component of this vaccine
Vaccine
Nimenrix
Indication
6 weeks to 99 years old
Usage
Prevent invasive meningococcal disease caused by Neisseria meningitidis A, C, Y, W-135
Manufacturer
Pfizer
HK Registration Number
HK-62095
Registration
HK registration since 2013
Price
HK$1500
Dosage & Schedule

For aged 6 weeks to 5 months: 3 doses, minimum 2-month interval between first two doses, then 1 booster dose at 12 months old or above


For aged 6-11 months: 2 doses with minimum 2-month interval and second dose given at 12 months old or above

For aged 1-99: 1 dose

Peak Incidence Age
Under 12 months, and between 16-23 years old
Characteristics
  • Contain extra Y and W-135 strain than the China meninococcal vaccine
  • Can be given as early as 6 weeks old
  • Though Hong Kong has a low meningococcal infection rate, vaccination is still recommended for high-risk group
High Risk Groups
Under 1 year old, borders in dormitories, students planning for overseas studies and travellers to high-risk countries
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, loss of appetite, vomiting, diarrhea and somnolence
Contraindication
  • Severe allergic reaction to any component of this vaccine
Vaccine
Menactra
Indication
9 months to 55 years old
Usage
Prevent invasive meningococcal disease caused by Neisseria meningitidis A, C, Y, W-135
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-60659
Registration
HK registration since 2011
Price
HK$1200
Dosage & Schedule

2 doses for over 9 months and under 23 months

1 dose for over 24 months

Peak Incidence Age
Below 1, 16 to 23
Characteristics
  • Contain extra Y and W-135 strain than the China meninococcal vaccine
  • Though Hong Kong has a low meningococcal infection rate, vaccination is still recommended for high-risk group
High Risk Groups
Under 1 year old, borders in dormitories, students planning for overseas studies and travellers to high-risk countries
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, loss of appetite, vomiting, diarrhea and somnolence
Contraindication
  • Severe allergic reaction to any component of this vaccine
Vaccine
Imojev
Indication
From 9 months onward
Usage
Prevention of Japanese encephalitis
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-62787
Registration
Australia TGA (2010), Hong Kong CHP (2014)
Price
HK$2100
Dosage & Schedule

9 months to 17 years old: 2 doses series, with interval of 12-24 months

18 years old and above: 1 dose only

Peak Incidence Age
Summer and rainy season
Characteristics
  • 99.2% of young children (9 to 18 months old) get protection 28 days after receiving one dose of Japanese encephalitis vaccine
High Risk Groups
Newborn to 14 years old , People who stay outdoor most of the time
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), unusual crying, loss of appetite, headache, vomiting and somnolence
Contraindication
  • Infant under 9 months old
  • Severe allergic reaction to any component of this vaccine
Vaccine
Rotateq
Indication
From 6 to 32 weeks infants
Usage
Rotavirus gastroenteritis caused by G1, G2, G3, G4 & G9 types
Manufacturer
MSD
HK Registration Number
HK-55037
Registration
HK registration since 2006
Price
HK$630
Dosage & Schedule

3 doses with at least 4 weeks apart, first dose to be taken before 15 weeks old

Peak Incidence Age
6 to 24 months
Characteristics
  • Pentavalent vaccine
High Risk Groups
4 to 23 months
Common Side Effects
Fever, irritability, loss of appetite, vomiting, diarrhea
Contraindication
  • Severe allergic reaction to any component of this vaccine
  • History of intussusception or uncorrected congenital malformation of the gastrointestinal tract that would predispose the infant to intussusception
  • History of severe combined immunodeficiency disease
Vaccine
Rotarix
Indication
From 6 to 24 weeks infants
Usage
Rotavirus gastroenteritis caused by G1 and non-G1 types
Manufacturer
GSK
HK Registration Number
HK-54546
Registration
HK registration since 2006
Price
HK$945
Dosage & Schedule

2 doses with at least 4 weeks apart, first dose to be taken before 20 weeks old

Peak Incidence Age
6 to 24 months
Characteristics
  • Early protction, infant can finished the 2 doses course as early as 10 weeks old
High Risk Groups
4 to 23 months
Common Side Effects
Fever, irritability, loss of appetite, vomiting, diarrhea
Contraindication
  • Severe allergic reaction to any component of this vaccine
  • History of intussusception or uncorrected congenital malformation of the gastrointestinal tract that would predispose the infant to intussusception
  • History of severe combined immunodeficiency disease
Vaccine
Infanrix-Hexa
Indication
From 6 weeks onwards
Usage
Prevention of diphtheria, tetanus, pertussis, poliomyelitis, invasive disease due to Haemophilus influenzae type b and hepatitis B
Manufacturer
GSK
HK Registration Number
HK-64010
Registration
HK registration since 2015
Price
HK$1050
Dosage & Schedule

4 doses at aged 2, 4, 6 months and 15-18 months


Peak Incidence Age
Infant
Characteristics
  • 30-40% more Pertussis prevention than traditional DTaP-IPV vaccine
  • Combine 5in1 & Hepatitis B vaccine, can reduce the total number of injections from 10 to 4
High Risk Groups
Infant
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), injection nodule, unusual crying, irritability, loss of appetite, vomiting, diarrhea and somnolence
Contraindication
  • Severe allergic reaction to any component of this vaccine
  • Encephalopathy of unknown cause, occurring within 7 days following previous vaccination with a pertussis containing vaccine
Vaccine
Pentaxim
Indication
From 2 months onward
Usage
Prevention of diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b.
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-56018
Registration
HK registration since 2007
Price
HK$990
Dosage & Schedule

4 doses at 2, 4, 6 months and 15-18 months

Peak Incidence Age
Infant
Characteristics
  • Combine DTaP-IPV & Hib vaccine, can reduce the total number of injections from 8 to 4
High Risk Groups
Infant
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), injection nodule, unusual crying, irritability, loss of appetite, vomiting, diarrhea and somnolence
Contraindication
  • Severe allergic reaction to any component of this vaccine
  • Encephalopathy of unknown cause, occurring within 7 days following previous vaccination with a pertussis containing vaccine
Vaccine
Act-HIB
Indication
2 months to 5 years old
Usage
Prevention of Haemophilus influenza type b infection
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-37568
Registration
HK registration since 1994
Price
HK$450
Dosage & Schedule

For aged 1.5-6 months: 4 doses with minimum 4-week interval for the first three doses, fourth dose at least 8 weeks after third dose and at 12 months old or above

For aged 7-11 months: 3 doses with minimum 4-week interval for the first two doses, third dose at least 8 weeks after second dose and at 12 months old or above

For aged 12-14 months: 2 doses with minimum 8-week interval

For aged 15-59 months: 1 dose

Peak Incidence Age
Infant
Characteristics
  • To reduce the number of injections, 5-in-1 or 6-in-1 vaccine can be considered as they already included this vaccine
High Risk Groups
3 months to 3 years old
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, loss of appetite and somnolence
Contraindication
  • Severe allergic reaction to any component of this vaccine
Vaccine
Prevenar 13
Indication
From 6 weeks onwards
Usage
Prevention of invasive disease caused by S.pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F
Manufacturer
Pfizer
HK Registration Number
HK-59600
Registration
HK registration since 2010
Price
HK$1500
Dosage & Schedule

For aged 6 weeks to under 6 months: 4 doses at aged 2, 4, 6 months and 12-15 months

For aged over 6 to under 12 months: 3 doses (dose 1 & 2 with minimum interval of 4 weeks; dose 2 & 3 with minimum interval of 8 weeks)

For aged over 12 to under 24 months: 2 doses with minimum interval of 8 weeks

For aged over 2: 1 dose

Peak Incidence Age
Below 2 and Above 65 years old
Characteristics
  • Conjugate vaccine can promote immune memory and provide long-term protection
  • Contain extra strains of protection over Prevnar and Synflorix
High Risk Groups
Infant, Immunodeficient individual, Functional or anatomic asplenia, Cochlear implants
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, loss of appetite, vomiting, diarrhea, upper respiratory tract infection, rash, eczema and itching
Contraindication
  • Severe allergic reaction to any component of this vaccine or any diphtheria toxoid-containing vaccine
  • During chemotherapy or radiotherapy
Vaccine
ProQuad
Indication
From 12 months onward
Usage
Prevention of measles, mumps, rubella, and varicella
Manufacturer
MSD
HK Registration Number
HK-54831
Registration
HK registration since 2006
Price
HK$1000
Dosage & Schedule

2 doses with 3 months interval

Peak Incidence Age
Aged 5-10
Characteristics
  • Early protection from 15 months old onwards
High Risk Groups
Young child, Pregnant women
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, vomiting, diarrhea, upper respiratory tract infection, rash and eczema
Contraindication
  • Pregnancy
  • Severe allergic reaction to any component of this vaccine
  • Immunodeficiency
Vaccine
M-M-R II
Indication
From 12 months onwards
Usage
Prevention of meales, mumps and rubella
Manufacturer
MSD
HK Registration Number
HK-64166
Registration
HK registration since 2015
Price
HK$600
Dosage & Schedule

2 doses with 3 months interval

Peak Incidence Age
Age 5-10
Characteristics
  • Early protection from 15 months old onwards
High Risk Groups
Young child, Pregnant women
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), upper respiratory tract infection and rash
Contraindication
  • Pregnancy
  • Severe allergic reaction to any component of this vaccine
  • Immunodeficiency
Vaccine
Varivax
Indication
From 12 months old onwards
Usage
Prevention of chickenpox
Manufacturer
MSD
HK Registration Number
HK-39958
Registration
HK registration since 1996
Price
HK$600
Dosage & Schedule

2 doses with at least 1 month interval

Peak Incidence Age
Age 10 and below
Characteristics
  • Early protection from 15 months old onwards
High Risk Groups
Young child, Pregnant women
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, vomiting, diarrhea, upper respiratory tract infection, rash and eczema
Contraindication
  • Pregnancy
  • Severe allergic reaction to any component of this vaccine
  • Immunodeficiency
Vaccine
Havrix 720 Junior
Indication
12 months of age and older
Usage
Hepatitis A virus
Manufacturer
GSK
HK Registration Number
HK-42693
Registration
HK registration since 1997
Price
HK$550
Dosage & Schedule

2 doses with 6 -12 months apart

Peak Incidence Age
Aged 9-12 and adolescence. Incidence increase with age
Characteristics
  • Protecton against Hepatitis A virus starts 28 days after 1st vaccination
High Risk Groups
Child care centre attendee and children who have started eating high-risk food such as fish and shellfish, Travellers to endemic areas of hepatitis A, Persons with chronic liver diseases.
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, loss of appetite, vomiting, diarrhea, headache, somnolence and arthralgia
Contraindication
  • Severe allergic reaction to any component of this vaccine
Vaccine
HBVaxPro 5mg
Indication
From birth to 15 years old
Usage
Hepatitis B virus
Manufacturer
MSD
HK Registration Number
HK-50265
Registration
HK registration since 2002
Price
HK$400
Dosage & Schedule

3 doses: 1-month interval between first and second doses, and third dose 5 months after second dose

Peak Incidence Age
At birth
Characteristics
  • Full response occurs in about 90–95% of individuals
High Risk Groups
Babies born to carrier mothers. People who share needles, syringes, or other drug-injection equipment. Travellers to regions with increased rates of hepatitis B. People with chronic liver disease, kidney disease, HIV infection, or diabetes
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability and headache
Contraindication
  • Severe allergic reaction to any component of this vaccine
Vaccine
Vaxigrip Tetra
Indication
Aged 6 months onwards
Usage
Influenza A&B and its complications
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-65577
Registration
HK registration 2018
Price
HK$400
Dosage & Schedule

1 dose annually

2 doses with minimum interval of 4 weeks for child below aged 9 who has never received any seasonal influenza vaccine

Peak Incidence Age
Under 12 and over 50 years old
Characteristics
  • Protection begin 2 weeks after vaccination
High Risk Groups
Children younger than 5, but especially children younger than 2 years, elderly and those with weaken immunity.
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability and headache
Contraindication
  • • Severe allergic reaction to any component of this vaccine
Vaccine
Typhim VI
Indication
2 years and above
Usage
Prevention of typhoid
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-36827
Registration
HK registration since 1993
Price
HK$500
Dosage & Schedule

The vaccine should be given at least two weeks prior to departure . Revaccination should be considered every three years for those at continuous risk of infection.

Peak Incidence Age
Those going to typhoid endemic areas
Characteristics
  • Antibodies appear after approximately 7 to 15 days after the injection. Persistence of the antibody response is at least 3 years.
High Risk Groups
Those going to typhoid endemic areas, in particular long-stay travellers and those visiting rural areas where food and beverage choices may be limited.
Common Side Effects
Mild redness and swelling at injection site
Contraindication
  • Fever
  • Severe allergic reaction (e.g. anaphylaxis) to any component of Typhim VI
Vaccine
Nimenrix
Indication
6 weeks to 99 years old
Usage
Prevent invasive meningococcal disease caused by Neisseria meningitidis A, C, Y, W-135
Manufacturer
Pfizer
HK Registration Number
HK-62095
Registration
HK registration since 2013
Price
HK$1500
Dosage & Schedule

For aged 6 weeks to 5 months: 3 doses, minimum 2-month interval between first two doses, then 1 booster dose at 12 months old or above


For aged 6-11 months: 2 doses with minimum 2-month interval and second dose given at 12 months old or above

For aged 1-99: 1 dose

Peak Incidence Age
Under 12 months, and between 16-23 years old
Characteristics
  • Contain extra Y and W-135 strain than the China meninococcal vaccine
  • Can be given as early as 6 weeks old
  • Though Hong Kong has a low meningococcal infection rate, vaccination is still recommended for high-risk group
High Risk Groups
Under 1 year old, borders in dormitories, students planning for overseas studies and travellers to high-risk countries
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, loss of appetite, vomiting, diarrhea and somnolence
Contraindication
  • Severe allergic reaction to any component of this vaccine
Vaccine
Rotateq
Indication
From 6 to 32 weeks infants
Usage
Rotavirus gastroenteritis caused by G1, G2, G3, G4 & G9 types
Manufacturer
MSD
HK Registration Number
HK-55037
Registration
HK registration since 2006
Price
HK$630
Dosage & Schedule

3 doses with at least 4 weeks apart, first dose to be taken before 15 weeks old

Peak Incidence Age
6 to 24 months
Characteristics
  • Pentavalent vaccine
High Risk Groups
4 to 23 months
Common Side Effects
Fever, irritability, loss of appetite, vomiting, diarrhea
Contraindication
  • Severe allergic reaction to any component of this vaccine
  • History of intussusception or uncorrected congenital malformation of the gastrointestinal tract that would predispose the infant to intussusception
  • History of severe combined immunodeficiency disease
Vaccine
Rotarix
Indication
From 6 to 24 weeks infants
Usage
Rotavirus gastroenteritis caused by G1 and non-G1 types
Manufacturer
GSK
HK Registration Number
HK-54546
Registration
HK registration since 2006
Price
HK$945
Dosage & Schedule

2 doses with at least 4 weeks apart, first dose to be taken before 20 weeks old

Peak Incidence Age
6 to 24 months
Characteristics
  • Early protction, infant can finished the 2 doses course as early as 10 weeks old
High Risk Groups
4 to 23 months
Common Side Effects
Fever, irritability, loss of appetite, vomiting, diarrhea
Contraindication
  • Severe allergic reaction to any component of this vaccine
  • History of intussusception or uncorrected congenital malformation of the gastrointestinal tract that would predispose the infant to intussusception
  • History of severe combined immunodeficiency disease
Vaccine
Infanrix-Hexa
Indication
From 6 weeks onwards
Usage
Prevention of diphtheria, tetanus, pertussis, poliomyelitis, invasive disease due to Haemophilus influenzae type b and hepatitis B
Manufacturer
GSK
HK Registration Number
HK-64010
Registration
HK registration since 2015
Price
HK$1050
Dosage & Schedule

4 doses at aged 2, 4, 6 months and 15-18 months


Peak Incidence Age
Infant
Characteristics
  • 30-40% more Pertussis prevention than traditional DTaP-IPV vaccine
  • Combine 5in1 & Hepatitis B vaccine, can reduce the total number of injections from 10 to 4
High Risk Groups
Infant
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), injection nodule, unusual crying, irritability, loss of appetite, vomiting, diarrhea and somnolence
Contraindication
  • Severe allergic reaction to any component of this vaccine
  • Encephalopathy of unknown cause, occurring within 7 days following previous vaccination with a pertussis containing vaccine
Vaccine
Pentaxim
Indication
From 2 months onward
Usage
Prevention of diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b.
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-56018
Registration
HK registration since 2007
Price
HK$990
Dosage & Schedule

4 doses at 2, 4, 6 months and 15-18 months

Peak Incidence Age
Infant
Characteristics
  • Combine DTaP-IPV & Hib vaccine, can reduce the total number of injections from 8 to 4
High Risk Groups
Infant
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), injection nodule, unusual crying, irritability, loss of appetite, vomiting, diarrhea and somnolence
Contraindication
  • Severe allergic reaction to any component of this vaccine
  • Encephalopathy of unknown cause, occurring within 7 days following previous vaccination with a pertussis containing vaccine
Vaccine
Act-HIB
Indication
2 months to 5 years old
Usage
Prevention of Haemophilus influenza type b infection
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-37568
Registration
HK registration since 1994
Price
HK$450
Dosage & Schedule

For aged 1.5-6 months: 4 doses with minimum 4-week interval for the first three doses, fourth dose at least 8 weeks after third dose and at 12 months old or above

For aged 7-11 months: 3 doses with minimum 4-week interval for the first two doses, third dose at least 8 weeks after second dose and at 12 months old or above

For aged 12-14 months: 2 doses with minimum 8-week interval

For aged 15-59 months: 1 dose

Peak Incidence Age
Infant
Characteristics
  • To reduce the number of injections, 5-in-1 or 6-in-1 vaccine can be considered as they already included this vaccine
High Risk Groups
3 months to 3 years old
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, loss of appetite and somnolence
Contraindication
  • Severe allergic reaction to any component of this vaccine
Vaccine
Pneumovax 23
Indication
Over 50 years old
Usage
Prevention of pneumococcal disease caused by 23 serotypes contained in the vaccine
Manufacturer
MSD
HK Registration Number
HK-64170
Registration
HK registration since 2015
Price
HK$400
Dosage & Schedule

1 dose only

Peak Incidence Age
Age 2 and above
Characteristics
  • Cover more serotypes than any other pneumococcal vaccine
High Risk Groups
Immunodeficient individual, Functional or anatomic asplenia, Cochlear implants
Common Side Effects
Mild redness and swelling at injection site
Contraindication
  • Severe allergic reaction (e.g. anaphylaxis) to any component of Pneumovax 23
Vaccine
Varivax
Indication
From 12 months old onwards
Usage
Prevention of chickenpox
Manufacturer
MSD
HK Registration Number
HK-39958
Registration
HK registration since 1996
Price
HK$600
Dosage & Schedule

2 doses with at least 1 month interval

Peak Incidence Age
Age 10 and below
Characteristics
  • Early protection from 15 months old onwards
High Risk Groups
Young child, Pregnant women
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, vomiting, diarrhea, upper respiratory tract infection, rash and eczema
Contraindication
  • Pregnancy
  • Severe allergic reaction to any component of this vaccine
  • Immunodeficiency
Vaccine
Twinrix
Indication
18 years and above
Usage
Hepatitis A&B viruses
Manufacturer
GSK
HK Registration Number
HK-43814
Registration
HK registration since 1998
Price
HK$1100
Dosage & Schedule

A series of 3 doses on a 0-,1-,6-month schedule

Peak Incidence Age
Incidence increase with age
Characteristics
  • Full response occurs in about 90–100% of individuals
High Risk Groups
Those born in Hong Kong prior to 1988 People who share needles, syringes, or other drug-injection equipment. Travellers to regions with increased rates of hepatitis B. People with chronic liver disease, kidney disease, HIV infection, or diabetes
Common Side Effects
Mild redness and swelling at injection site
Contraindication
  • Severe allergic reaction (e.g. anaphylaxis) to any component of Twinrix
Vaccine
Havrix 720 Junior
Indication
12 months of age and older
Usage
Hepatitis A virus
Manufacturer
GSK
HK Registration Number
HK-42693
Registration
HK registration since 1997
Price
HK$550
Dosage & Schedule

2 doses with 6 -12 months apart

Peak Incidence Age
Aged 9-12 and adolescence. Incidence increase with age
Characteristics
  • Protecton against Hepatitis A virus starts 28 days after 1st vaccination
High Risk Groups
Child care centre attendee and children who have started eating high-risk food such as fish and shellfish, Travellers to endemic areas of hepatitis A, Persons with chronic liver diseases.
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, loss of appetite, vomiting, diarrhea, headache, somnolence and arthralgia
Contraindication
  • Severe allergic reaction to any component of this vaccine
Vaccine
HBVaxPro 5mg
Indication
From birth to 15 years old
Usage
Hepatitis B virus
Manufacturer
MSD
HK Registration Number
HK-50265
Registration
HK registration since 2002
Price
HK$400
Dosage & Schedule

3 doses: 1-month interval between first and second doses, and third dose 5 months after second dose

Peak Incidence Age
At birth
Characteristics
  • Full response occurs in about 90–95% of individuals
High Risk Groups
Babies born to carrier mothers. People who share needles, syringes, or other drug-injection equipment. Travellers to regions with increased rates of hepatitis B. People with chronic liver disease, kidney disease, HIV infection, or diabetes
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability and headache
Contraindication
  • Severe allergic reaction to any component of this vaccine
Vaccine
Zostavax
Indication
Over 50 years old
Usage
Prevention of shingles
Manufacturer
MSD
HK Registration Number
HK-55419
Registration
HK registration since 2007
Price
HK$1500
Dosage & Schedule

1 dose only

Peak Incidence Age
Over 50 years old
Characteristics
  • Also prevent post-herpetic neuralgia as well as reduce acute and chronic zoster-associated pain
High Risk Groups
Previous shingles infection, Immunodeficient individual
Common Side Effects
Mild redness and swelling at injection site. Ocasionally, fever or headache might occur
Contraindication
  • History of anaphylactic reaction to gelatin, neomycin, or any other component of the vaccine
  • Immunosuppression or Immunodeficiency
Vaccine
Verorab
Indication
12 years and above
Usage
Prevention against rabies
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-53345
Registration
HK registration since 2005
Price
HK$700
Dosage & Schedule

Three doses at Day 0, Day 7 and Day 28 for primary vaccination.

Peak Incidence Age
Vaccination should be initiated immediately at the slightest risk of rabies contamination.
Characteristics
  • It can be used before and after exposure to the rabies virus, as a primary vaccination or as a booster dose.
High Risk Groups
People in contact with potentially rabid animal species (such as dogs, cats, skunks, raccoons, bats). Adults living in or travelling to enzootic areas.
Common Side Effects
Mild redness and swelling at injection site
Contraindication
  • Fever
  • Severe allergic reaction (e.g. anaphylaxis) to any component of Verorab
Vaccine
Tetavax
Indication
12 years and above
Usage
Prevention against tetanus
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-57877
Registration
HK registration since 2009
Price
HK$300
Dosage & Schedule

During childhood, five doses are recommended, booster doses every ten years are recommended

Peak Incidence Age
Travellers to countries where health services are difficult to access
Characteristics
  • Pregnant women should make sure they are up to date on their tetanus immunization in order to prevent neonatal tetanus
High Risk Groups
Those who are not up to date on their tetanus immunization, a booster should be given within 48 hours of an injury
Common Side Effects
Mild redness and swelling at injection site
Contraindication
  • Fever
  • Severe allergic reaction (e.g. anaphylaxis) to any component of Tetavax
Vaccine
Imovax Polio
Indication
Travellers to polio-infected countries and areas should have another dose of polio vaccine before departure
Usage
Prevention against Polio
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-06083
Registration
HK registration since 1979
Price
HK$400
Dosage & Schedule

At least 2 weeks before departure

Peak Incidence Age
Travellers to polio-infected countries and areas
Characteristics
  • For infants travelling to areas of high risk, the primary doses of vaccines are recommended to be completed prior to departure
High Risk Groups
Travellers to polio-infected countries and areas
Common Side Effects
Mild redness and swelling at injection site
Contraindication
  • Fever
  • Severe allergic reaction (e.g. anaphylaxis) to any component of Imovax Polio
Suitable for
All pregnant women (especially those above 35)
Turn around time
2 weeks
Specimen
18ml blood
Specification

To screen for Down syndrome and other chromosomal disorders without risks of miscarriage

Suitable for
Any sexually active female
Turn around time
5 days
Specimen
Vaginal swab
Specification

Test over 33 types of HPV DNA

Suitable for
Age 0-12 years old
Turn around time
21 days
Specimen
Buccal swab/saliva
Specification

Based on the results from the GWAS (Genome-Wide Association Study). This talent test will unlock the full scale of your child's physical, mental and intellectual potential. Understanding these will help establish targeted child-rearing methods and lay a solid foundation for your child's development

Suitable for
In order to protect clients' best interest and to ensure a test accuracy of 99.9%, this test requires gestational age of 7 weeks or above subject to ultrasound examination(CRL>10mm)
Turn around time
One day
Specimen
12 ml blood
Specification

If client completes blood draw at the clinic before 12pm, they will receive an e-report via email before 7 pm. The accuracy of this test is 99.9%

Suitable for
Any kids
Turn around time
6 weeks
Specimen
6ml blood or 6 buccal swabs
Specification

Screen over 90 genes for 10 most common diseases during childhood

Suitable for
People who are vaccinated against HPV
Turn around time
5 working days
Specimen
3ml clotted-blood
Specification

Designed for people who are vaccinated against HPV

The latest HPV antibody test covers all antibodies of the nine-valent HPV vaccine, including HPV6,11,16,18,31,33,45,52,58

According to the degree of antibody-antigen binding, you can accurately determine the level of 9 antibodies through quantitative experiments

Suitable for
7 weeks pregnant or above
Turn around time
6 days
Specimen
18ml blood
Specification

Non-invasive prenatal parentage blood test

Suitable for
7 weeks gestation or above (for male fetus)
Turn around time
6 days
Specimen
6ml blood
Specification

Need to perform MBY test first. Compares the DNA of the child within maternal blood with the alleged father to determine if half of the DNA between them is identical

Suitable for
10 weeks gestation or above (for female fetus)
Turn around time
10 days
Specimen
20ml blood
Specification

DNA profile of the baby is determined from free-floating fetal cells found in the mother's blood sample. The baby’s profile is compared to the DNA profile of the man tested

Suitable for
From newborn to adult
Turn around time
5 days
Specimen
6ml blood or 4 buccal swabs
Specification

Postnatal Parentage Tests report can be used for private or legal purpose, such as for immigration

Suitable for
Anyone with allergic symptoms such as hives, skin rash, nasal congestion, runny nose, itchy eyes, etc
Turn around time
2 weeks
Specimen
3ml blood
Specification

Measure the presence of IgE antibodies in the blood. Detect 52 different types of enviornmental allergens and 54 different types of food allergens

Suitable for
Chinese over 25 years old
Turn around time
1 week
Specimen
10ml blood
Specification

Using the lastest BamHi-W gene and CpG technology. EBV DNA load gives better sensitivity and specificity profile as a screening tool for nasopharyngeal cancer

Suitable for
Families with breast and ovarian and or prostate cancer
Turn around time
1 week
Specimen
6ml blood
Specification

BRCA1 & 2 Mutation Screening searches for up to 90%, 29 regions of BRCA1 and BRCA2 pathogenic mutations occurred in Asian population

Suitable for
Individual with (i) multiple family members affected with the same cancer (e.g. breast cancer) or related cancers (e.g. breast and ovarian cancer, or colon and uterine cancer), or (ii) two or more first-degree relatives with rare tumours
Turn around time
30 days
Specimen
6ml blood or 6 buccal swabs
Specification

Cancer has always ranked the number one killer worldwide and everyone knows that. However, not everyone knows that cancer can be predicted and prevented. Identifying the inheritance of cancer genes opens up chances for early preventive measures. Can either choose to screen for all 200 cancer types or 1 cancer type only

Suitable for
Individuals who cannot go through colonoscopy
Turn around time
1 week
Specimen
10ml blood
Specification

SEPT9 is closely related to colorectal cancer carcinogenesis when the promoter region is hypermethylated and the transcription is compromised. Studies showed methylated Septin9 is a reliable biomarker for colorectal cancer with sensitivity and specificity ranging from 69% - 88% and 87% - 98%, respectively

Suitable for
Healthy individuals at all ages, Individual with family history of cancer
Turn around time
6 weeks
Specimen
10ml blood
Specification

A tumour itself is the major source of tumour DNA and dying tumour cells could release small pieces of their DNA into the bloodstream. These pieces are referred to circulating tumour DNA (ctDNA). Owing to its high specificity to tumour, ctDNA is regarded as an effective yet non-invasive cancer biomarker. ctDNA technology could discover the presence of mutation before it develops into malignant tumours

Suitable for
Family history of any heart disease, high risk life styles, such as smoking, excessive intake of alcohol or always under pressure
Turn around time
6 weeks
Specimen
6ml blood or 6 buccal swabs
Specification

A series of genetic sequencing tests specified for detecting inherited risk that leads to cardiac death

Suitable for
Anyone over 30 years old
Turn around time
6 weeks
Specimen
6ml blood or 6 buccal swabs
Specification

Screen over 160 genes for 10 most common diseases at middle age

Suitable for
Any healthy person
Turn around time
6 weeks
Specimen
6ml blood or 6 buccal swabs
Specification

1. musculoskeletal, 2. nervous system, 3. metabolic function, 4. endocrine system, 5. blood, 6. head & neck, 7. GI tract and liver, 8. immune system, 9. kidney, 10. lung, 11. intellectual development

Suitable for
People of all age groups, including those who would like to understand if they are at risk of any hereditary diseases. It can meet all of your genetic testing needs
Turn around time
6 weeks
Specimen
6ml blood
Specification

Take a step ahead of health management with the most comprehensive test. Total solution for hereditary testing with a screening of over 2,700 genes and over 500 / 900 hereditary diseases. From cancer, development disorder to cardiac diseases, various asymptomatic genetic mutations and related health risks can be identified by this premium genetic test

Suitable for
Spouses planning to give birth, particularly for those with hereditary diseases / in consanguine marriage / conducting in-vitro fertilisation
Turn around time
6 weeks
Specimen
6ml blood or 6 buccal swabs
Specification

Carrier with only one copy of mutation for a recessive disease has no symptoms. With two carriers as parents, the child will have up to 25% chance of inheriting a carrier gene and being born with a severe disease. Even if the child is not born with disease, there is still a 50% chance that the child will become a carrier, with the defective gene affecting offspring constantly

HPV Vaccine
Vaccine
Gardasil 9
Indication
Age 9 or above
Usage
Reduce 90% of cervical cancer, 90-95% of anal cancer and their precancerous growth
Manufacturer
MSD
HK Registration Number
HK-64239
Registration
HK registration since 2015
Price
HK$1800
Dosage & Schedule

Age 9-14: 2 doses series on a 0-,6-month schedule

Age 15 or over: 3 doses series on a 0-,2-,6-month schedule

Peak Incidence Age
Age 26-30, and Age 46-55
Characteristics
  • Provide extra 85-90% of protection against Vaginal and Cervical cancer when compare to other HPV vaccine.
High Risk Groups
Recurrent HPV infection, Immunodeficient individual, Smoker
Common Side Effects
Mild redness and swelling at injection site. Occasionally, fever or headache might occur
Contraindication
  • Hypersensitivity, including severe allergic reactions to yeast (a vaccine component), or after a previous dose of GARDASIL 9 or GARDASIL
  • Pregnant women
  • Those with fever or suffering from moderate to severe illness
Meningococcal Group B Vaccine
Vaccine
Bexsero
Indication
2 months old onwards
Usage
Prevent invasive meningococcal disease by Neisseria meningitidis B
Manufacturer
GSK
HK Registration Number
HK-66268
Registration
HK registration since 2019
Price
HK$1800
Dosage & Schedule

2 months old : 4 doses, at least 1 month between each dose

3-23 months old : 3 doses, at least 2 months between each dose

2 years old and above : 2 doses, at least 1 month apart

Peak Incidence Age
Aged below 1, and 16-23
Characteristics
  • The only Meningococcal B vaccine indicated for paediatric patients
  • Though Hong Kong has a low meningococcal infection rate, vaccination is still recommended for high-risk group
High Risk Groups
Immunodeficient individual, borders in dormitorie, students planning for overseas studies and travellers to high-risk countries
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), unusual crying, irritability, loss of appetite, vomiting, diarrhea, somnolence and rash
Contraindication
  • Severe allergic reaction to any component of this vaccine
Nimenrix - Meningococcal (Group A,C,Y,W-135) Vaccine
Vaccine
Nimenrix
Indication
6 weeks to 99 years old
Usage
Prevent invasive meningococcal disease caused by Neisseria meningitidis A, C, Y, W-135
Manufacturer
Pfizer
HK Registration Number
HK-62095
Registration
HK registration since 2013
Price
HK$1500
Dosage & Schedule

For aged 6 weeks to 5 months: 3 doses, minimum 2-month interval between first two doses, then 1 booster dose at 12 months old or above


For aged 6-11 months: 2 doses with minimum 2-month interval and second dose given at 12 months old or above

For aged 1-99: 1 dose

Peak Incidence Age
Under 12 months, and between 16-23 years old
Characteristics
  • Contain extra Y and W-135 strain than the China meninococcal vaccine
  • Can be given as early as 6 weeks old
  • Though Hong Kong has a low meningococcal infection rate, vaccination is still recommended for high-risk group
High Risk Groups
Under 1 year old, borders in dormitories, students planning for overseas studies and travellers to high-risk countries
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, loss of appetite, vomiting, diarrhea and somnolence
Contraindication
  • Severe allergic reaction to any component of this vaccine
Menactra - Meningococcal (Group A,C,Y,W-135) Vaccine
Vaccine
Menactra
Indication
9 months to 55 years old
Usage
Prevent invasive meningococcal disease caused by Neisseria meningitidis A, C, Y, W-135
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-60659
Registration
HK registration since 2011
Price
HK$1200
Dosage & Schedule

2 doses for over 9 months and under 23 months

1 dose for over 24 months

Peak Incidence Age
Below 1, 16 to 23
Characteristics
  • Contain extra Y and W-135 strain than the China meninococcal vaccine
  • Though Hong Kong has a low meningococcal infection rate, vaccination is still recommended for high-risk group
High Risk Groups
Under 1 year old, borders in dormitories, students planning for overseas studies and travellers to high-risk countries
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, loss of appetite, vomiting, diarrhea and somnolence
Contraindication
  • Severe allergic reaction to any component of this vaccine
Japanese Encephalitis Vaccine
Vaccine
Imojev
Indication
From 9 months onward
Usage
Prevention of Japanese encephalitis
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-62787
Registration
Australia TGA (2010), Hong Kong CHP (2014)
Price
HK$2100
Dosage & Schedule

9 months to 17 years old: 2 doses series, with interval of 12-24 months

18 years old and above: 1 dose only

Peak Incidence Age
Summer and rainy season
Characteristics
  • 99.2% of young children (9 to 18 months old) get protection 28 days after receiving one dose of Japanese encephalitis vaccine
High Risk Groups
Newborn to 14 years old , People who stay outdoor most of the time
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), unusual crying, loss of appetite, headache, vomiting and somnolence
Contraindication
  • Infant under 9 months old
  • Severe allergic reaction to any component of this vaccine
Rotavirus Vaccine
Vaccine
Rotateq
Indication
From 6 to 32 weeks infants
Usage
Rotavirus gastroenteritis caused by G1, G2, G3, G4 & G9 types
Manufacturer
MSD
HK Registration Number
HK-55037
Registration
HK registration since 2006
Price
HK$630
Dosage & Schedule

3 doses with at least 4 weeks apart, first dose to be taken before 15 weeks old

Peak Incidence Age
6 to 24 months
Characteristics
  • Pentavalent vaccine
High Risk Groups
4 to 23 months
Common Side Effects
Fever, irritability, loss of appetite, vomiting, diarrhea
Contraindication
  • Severe allergic reaction to any component of this vaccine
  • History of intussusception or uncorrected congenital malformation of the gastrointestinal tract that would predispose the infant to intussusception
  • History of severe combined immunodeficiency disease
Rotavirus Vaccine
Vaccine
Rotarix
Indication
From 6 to 24 weeks infants
Usage
Rotavirus gastroenteritis caused by G1 and non-G1 types
Manufacturer
GSK
HK Registration Number
HK-54546
Registration
HK registration since 2006
Price
HK$945
Dosage & Schedule

2 doses with at least 4 weeks apart, first dose to be taken before 20 weeks old

Peak Incidence Age
6 to 24 months
Characteristics
  • Early protction, infant can finished the 2 doses course as early as 10 weeks old
High Risk Groups
4 to 23 months
Common Side Effects
Fever, irritability, loss of appetite, vomiting, diarrhea
Contraindication
  • Severe allergic reaction to any component of this vaccine
  • History of intussusception or uncorrected congenital malformation of the gastrointestinal tract that would predispose the infant to intussusception
  • History of severe combined immunodeficiency disease
6-in-1 Vaccine
Vaccine
Infanrix-Hexa
Indication
From 6 weeks onwards
Usage
Prevention of diphtheria, tetanus, pertussis, poliomyelitis, invasive disease due to Haemophilus influenzae type b and hepatitis B
Manufacturer
GSK
HK Registration Number
HK-64010
Registration
HK registration since 2015
Price
HK$1050
Dosage & Schedule

4 doses at aged 2, 4, 6 months and 15-18 months


Peak Incidence Age
Infant
Characteristics
  • 30-40% more Pertussis prevention than traditional DTaP-IPV vaccine
  • Combine 5in1 & Hepatitis B vaccine, can reduce the total number of injections from 10 to 4
High Risk Groups
Infant
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), injection nodule, unusual crying, irritability, loss of appetite, vomiting, diarrhea and somnolence
Contraindication
  • Severe allergic reaction to any component of this vaccine
  • Encephalopathy of unknown cause, occurring within 7 days following previous vaccination with a pertussis containing vaccine
5-in-1 Vaccine
Vaccine
Pentaxim
Indication
From 2 months onward
Usage
Prevention of diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b.
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-56018
Registration
HK registration since 2007
Price
HK$990
Dosage & Schedule

4 doses at 2, 4, 6 months and 15-18 months

Peak Incidence Age
Infant
Characteristics
  • Combine DTaP-IPV & Hib vaccine, can reduce the total number of injections from 8 to 4
High Risk Groups
Infant
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), injection nodule, unusual crying, irritability, loss of appetite, vomiting, diarrhea and somnolence
Contraindication
  • Severe allergic reaction to any component of this vaccine
  • Encephalopathy of unknown cause, occurring within 7 days following previous vaccination with a pertussis containing vaccine
Haemophilus influenza type b (Hib) vaccine
Vaccine
Act-HIB
Indication
2 months to 5 years old
Usage
Prevention of Haemophilus influenza type b infection
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-37568
Registration
HK registration since 1994
Price
HK$450
Dosage & Schedule

For aged 1.5-6 months: 4 doses with minimum 4-week interval for the first three doses, fourth dose at least 8 weeks after third dose and at 12 months old or above

For aged 7-11 months: 3 doses with minimum 4-week interval for the first two doses, third dose at least 8 weeks after second dose and at 12 months old or above

For aged 12-14 months: 2 doses with minimum 8-week interval

For aged 15-59 months: 1 dose

Peak Incidence Age
Infant
Characteristics
  • To reduce the number of injections, 5-in-1 or 6-in-1 vaccine can be considered as they already included this vaccine
High Risk Groups
3 months to 3 years old
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, loss of appetite and somnolence
Contraindication
  • Severe allergic reaction to any component of this vaccine
13-Valent Pneumococcal Conjugate Vaccine
Vaccine
Prevenar 13
Indication
From 6 weeks onwards
Usage
Prevention of invasive disease caused by S.pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F
Manufacturer
Pfizer
HK Registration Number
HK-59600
Registration
HK registration since 2010
Price
HK$1500
Dosage & Schedule

For aged 6 weeks to under 6 months: 4 doses at aged 2, 4, 6 months and 12-15 months

For aged over 6 to under 12 months: 3 doses (dose 1 & 2 with minimum interval of 4 weeks; dose 2 & 3 with minimum interval of 8 weeks)

For aged over 12 to under 24 months: 2 doses with minimum interval of 8 weeks

For aged over 2: 1 dose

Peak Incidence Age
Below 2 and Above 65 years old
Characteristics
  • Conjugate vaccine can promote immune memory and provide long-term protection
  • Contain extra strains of protection over Prevnar and Synflorix
High Risk Groups
Infant, Immunodeficient individual, Functional or anatomic asplenia, Cochlear implants
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, loss of appetite, vomiting, diarrhea, upper respiratory tract infection, rash, eczema and itching
Contraindication
  • Severe allergic reaction to any component of this vaccine or any diphtheria toxoid-containing vaccine
  • During chemotherapy or radiotherapy
23-Valent Pneumococcal Conjugate Vaccine
Vaccine
Pneumovax 23
Indication
Over 50 years old
Usage
Prevention of pneumococcal disease caused by 23 serotypes contained in the vaccine
Manufacturer
MSD
HK Registration Number
HK-64170
Registration
HK registration since 2015
Price
HK$400
Dosage & Schedule

1 dose only

Peak Incidence Age
Age 2 and above
Characteristics
  • Cover more serotypes than any other pneumococcal vaccine
High Risk Groups
Immunodeficient individual, Functional or anatomic asplenia, Cochlear implants
Common Side Effects
Mild redness and swelling at injection site
Contraindication
  • Severe allergic reaction (e.g. anaphylaxis) to any component of Pneumovax 23
MMRV Vaccine
Vaccine
ProQuad
Indication
From 12 months onward
Usage
Prevention of measles, mumps, rubella, and varicella
Manufacturer
MSD
HK Registration Number
HK-54831
Registration
HK registration since 2006
Price
HK$1000
Dosage & Schedule

2 doses with 3 months interval

Peak Incidence Age
Aged 5-10
Characteristics
  • Early protection from 15 months old onwards
High Risk Groups
Young child, Pregnant women
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, vomiting, diarrhea, upper respiratory tract infection, rash and eczema
Contraindication
  • Pregnancy
  • Severe allergic reaction to any component of this vaccine
  • Immunodeficiency
MMR Vaccine
Vaccine
M-M-R II
Indication
From 12 months onwards
Usage
Prevention of meales, mumps and rubella
Manufacturer
MSD
HK Registration Number
HK-64166
Registration
HK registration since 2015
Price
HK$600
Dosage & Schedule

2 doses with 3 months interval

Peak Incidence Age
Age 5-10
Characteristics
  • Early protection from 15 months old onwards
High Risk Groups
Young child, Pregnant women
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), upper respiratory tract infection and rash
Contraindication
  • Pregnancy
  • Severe allergic reaction to any component of this vaccine
  • Immunodeficiency
Chickenpox vaccine
Vaccine
Varivax
Indication
From 12 months old onwards
Usage
Prevention of chickenpox
Manufacturer
MSD
HK Registration Number
HK-39958
Registration
HK registration since 1996
Price
HK$600
Dosage & Schedule

2 doses with at least 1 month interval

Peak Incidence Age
Age 10 and below
Characteristics
  • Early protection from 15 months old onwards
High Risk Groups
Young child, Pregnant women
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, vomiting, diarrhea, upper respiratory tract infection, rash and eczema
Contraindication
  • Pregnancy
  • Severe allergic reaction to any component of this vaccine
  • Immunodeficiency
Hepatitis A&B vaccine
Vaccine
Twinrix
Indication
18 years and above
Usage
Hepatitis A&B viruses
Manufacturer
GSK
HK Registration Number
HK-43814
Registration
HK registration since 1998
Price
HK$1100
Dosage & Schedule

A series of 3 doses on a 0-,1-,6-month schedule

Peak Incidence Age
Incidence increase with age
Characteristics
  • Full response occurs in about 90–100% of individuals
High Risk Groups
Those born in Hong Kong prior to 1988 People who share needles, syringes, or other drug-injection equipment. Travellers to regions with increased rates of hepatitis B. People with chronic liver disease, kidney disease, HIV infection, or diabetes
Common Side Effects
Mild redness and swelling at injection site
Contraindication
  • Severe allergic reaction (e.g. anaphylaxis) to any component of Twinrix
Hepatitis A Vaccine
Vaccine
Havrix 720 Junior
Indication
12 months of age and older
Usage
Hepatitis A virus
Manufacturer
GSK
HK Registration Number
HK-42693
Registration
HK registration since 1997
Price
HK$550
Dosage & Schedule

2 doses with 6 -12 months apart

Peak Incidence Age
Aged 9-12 and adolescence. Incidence increase with age
Characteristics
  • Protecton against Hepatitis A virus starts 28 days after 1st vaccination
High Risk Groups
Child care centre attendee and children who have started eating high-risk food such as fish and shellfish, Travellers to endemic areas of hepatitis A, Persons with chronic liver diseases.
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, loss of appetite, vomiting, diarrhea, headache, somnolence and arthralgia
Contraindication
  • Severe allergic reaction to any component of this vaccine
Hepatitis B Vaccine
Vaccine
HBVaxPro 5mg
Indication
From birth to 15 years old
Usage
Hepatitis B virus
Manufacturer
MSD
HK Registration Number
HK-50265
Registration
HK registration since 2002
Price
HK$400
Dosage & Schedule

3 doses: 1-month interval between first and second doses, and third dose 5 months after second dose

Peak Incidence Age
At birth
Characteristics
  • Full response occurs in about 90–95% of individuals
High Risk Groups
Babies born to carrier mothers. People who share needles, syringes, or other drug-injection equipment. Travellers to regions with increased rates of hepatitis B. People with chronic liver disease, kidney disease, HIV infection, or diabetes
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability and headache
Contraindication
  • Severe allergic reaction to any component of this vaccine
Herpes Zoster Vaccine
Vaccine
Zostavax
Indication
Over 50 years old
Usage
Prevention of shingles
Manufacturer
MSD
HK Registration Number
HK-55419
Registration
HK registration since 2007
Price
HK$1500
Dosage & Schedule

1 dose only

Peak Incidence Age
Over 50 years old
Characteristics
  • Also prevent post-herpetic neuralgia as well as reduce acute and chronic zoster-associated pain
High Risk Groups
Previous shingles infection, Immunodeficient individual
Common Side Effects
Mild redness and swelling at injection site. Ocasionally, fever or headache might occur
Contraindication
  • History of anaphylactic reaction to gelatin, neomycin, or any other component of the vaccine
  • Immunosuppression or Immunodeficiency
Quadrivalent Flu Vaccine
Vaccine
Vaxigrip Tetra
Indication
Aged 6 months onwards
Usage
Influenza A&B and its complications
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-65577
Registration
HK registration 2018
Price
HK$400
Dosage & Schedule

1 dose annually

2 doses with minimum interval of 4 weeks for child below aged 9 who has never received any seasonal influenza vaccine

Peak Incidence Age
Under 12 and over 50 years old
Characteristics
  • Protection begin 2 weeks after vaccination
High Risk Groups
Children younger than 5, but especially children younger than 2 years, elderly and those with weaken immunity.
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability and headache
Contraindication
  • • Severe allergic reaction to any component of this vaccine
Typhoid vaccine
Vaccine
Typhim VI
Indication
2 years and above
Usage
Prevention of typhoid
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-36827
Registration
HK registration since 1993
Price
HK$500
Dosage & Schedule

The vaccine should be given at least two weeks prior to departure . Revaccination should be considered every three years for those at continuous risk of infection.

Peak Incidence Age
Those going to typhoid endemic areas
Characteristics
  • Antibodies appear after approximately 7 to 15 days after the injection. Persistence of the antibody response is at least 3 years.
High Risk Groups
Those going to typhoid endemic areas, in particular long-stay travellers and those visiting rural areas where food and beverage choices may be limited.
Common Side Effects
Mild redness and swelling at injection site
Contraindication
  • Fever
  • Severe allergic reaction (e.g. anaphylaxis) to any component of Typhim VI
Rabies vaccine
Vaccine
Verorab
Indication
12 years and above
Usage
Prevention against rabies
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-53345
Registration
HK registration since 2005
Price
HK$700
Dosage & Schedule

Three doses at Day 0, Day 7 and Day 28 for primary vaccination.

Peak Incidence Age
Vaccination should be initiated immediately at the slightest risk of rabies contamination.
Characteristics
  • It can be used before and after exposure to the rabies virus, as a primary vaccination or as a booster dose.
High Risk Groups
People in contact with potentially rabid animal species (such as dogs, cats, skunks, raccoons, bats). Adults living in or travelling to enzootic areas.
Common Side Effects
Mild redness and swelling at injection site
Contraindication
  • Fever
  • Severe allergic reaction (e.g. anaphylaxis) to any component of Verorab
Tetanus vaccine
Vaccine
Tetavax
Indication
12 years and above
Usage
Prevention against tetanus
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-57877
Registration
HK registration since 2009
Price
HK$300
Dosage & Schedule

During childhood, five doses are recommended, booster doses every ten years are recommended

Peak Incidence Age
Travellers to countries where health services are difficult to access
Characteristics
  • Pregnant women should make sure they are up to date on their tetanus immunization in order to prevent neonatal tetanus
High Risk Groups
Those who are not up to date on their tetanus immunization, a booster should be given within 48 hours of an injury
Common Side Effects
Mild redness and swelling at injection site
Contraindication
  • Fever
  • Severe allergic reaction (e.g. anaphylaxis) to any component of Tetavax
Polio vaccine
Vaccine
Imovax Polio
Indication
Travellers to polio-infected countries and areas should have another dose of polio vaccine before departure
Usage
Prevention against Polio
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-06083
Registration
HK registration since 1979
Price
HK$400
Dosage & Schedule

At least 2 weeks before departure

Peak Incidence Age
Travellers to polio-infected countries and areas
Characteristics
  • For infants travelling to areas of high risk, the primary doses of vaccines are recommended to be completed prior to departure
High Risk Groups
Travellers to polio-infected countries and areas
Common Side Effects
Mild redness and swelling at injection site
Contraindication
  • Fever
  • Severe allergic reaction (e.g. anaphylaxis) to any component of Imovax Polio
Non-invasive Prenatal Screening (NIPT)
Suitable for
All pregnant women (especially those above 35)
Turn around time
2 weeks
Specimen
18ml blood
Specification

To screen for Down syndrome and other chromosomal disorders without risks of miscarriage

EBV DNA Test - Early Nasopharyngeal Cancer Detection
Suitable for
Chinese over 25 years old
Turn around time
1 week
Specimen
10ml blood
Specification

Using the lastest BamHi-W gene and CpG technology. EBV DNA load gives better sensitivity and specificity profile as a screening tool for nasopharyngeal cancer

BRCA1 & 2 Mutation Screening (OBB)
Suitable for
Families with breast and ovarian and or prostate cancer
Turn around time
1 week
Specimen
6ml blood
Specification

BRCA1 & 2 Mutation Screening searches for up to 90%, 29 regions of BRCA1 and BRCA2 pathogenic mutations occurred in Asian population

Cancer Health Risk Assessment
Suitable for
Individual with (i) multiple family members affected with the same cancer (e.g. breast cancer) or related cancers (e.g. breast and ovarian cancer, or colon and uterine cancer), or (ii) two or more first-degree relatives with rare tumours
Turn around time
30 days
Specimen
6ml blood or 6 buccal swabs
Specification

Cancer has always ranked the number one killer worldwide and everyone knows that. However, not everyone knows that cancer can be predicted and prevented. Identifying the inheritance of cancer genes opens up chances for early preventive measures. Can either choose to screen for all 200 cancer types or 1 cancer type only

Cardiac Health Risk Assessment
Suitable for
Family history of any heart disease, high risk life styles, such as smoking, excessive intake of alcohol or always under pressure
Turn around time
6 weeks
Specimen
6ml blood or 6 buccal swabs
Specification

A series of genetic sequencing tests specified for detecting inherited risk that leads to cardiac death

Hereditary Risk Assessment - Senior Panel
Suitable for
Anyone over 30 years old
Turn around time
6 weeks
Specimen
6ml blood or 6 buccal swabs
Specification

Screen over 160 genes for 10 most common diseases at middle age

Hereditary Risk Assessment - Specific target panel
Suitable for
Any healthy person
Turn around time
6 weeks
Specimen
6ml blood or 6 buccal swabs
Specification

1. musculoskeletal, 2. nervous system, 3. metabolic function, 4. endocrine system, 5. blood, 6. head & neck, 7. GI tract and liver, 8. immune system, 9. kidney, 10. lung, 11. intellectual development

Hereditary Risk Assessment
Suitable for
People of all age groups, including those who would like to understand if they are at risk of any hereditary diseases. It can meet all of your genetic testing needs
Turn around time
6 weeks
Specimen
6ml blood
Specification

Take a step ahead of health management with the most comprehensive test. Total solution for hereditary testing with a screening of over 2,700 genes and over 500 / 900 hereditary diseases. From cancer, development disorder to cardiac diseases, various asymptomatic genetic mutations and related health risks can be identified by this premium genetic test

Carrier Risk Assessment Test
Suitable for
Spouses planning to give birth, particularly for those with hereditary diseases / in consanguine marriage / conducting in-vitro fertilisation
Turn around time
6 weeks
Specimen
6ml blood or 6 buccal swabs
Specification

Carrier with only one copy of mutation for a recessive disease has no symptoms. With two carriers as parents, the child will have up to 25% chance of inheriting a carrier gene and being born with a severe disease. Even if the child is not born with disease, there is still a 50% chance that the child will become a carrier, with the defective gene affecting offspring constantly

Septin9 - Early Colorectal Cancer Detection
Suitable for
Individuals who cannot go through colonoscopy
Turn around time
1 week
Specimen
10ml blood
Specification

SEPT9 is closely related to colorectal cancer carcinogenesis when the promoter region is hypermethylated and the transcription is compromised. Studies showed methylated Septin9 is a reliable biomarker for colorectal cancer with sensitivity and specificity ranging from 69% - 88% and 87% - 98%, respectively

ctDNA - Early Cancer Screening
Suitable for
Healthy individuals at all ages, Individual with family history of cancer
Turn around time
6 weeks
Specimen
10ml blood
Specification

A tumour itself is the major source of tumour DNA and dying tumour cells could release small pieces of their DNA into the bloodstream. These pieces are referred to circulating tumour DNA (ctDNA). Owing to its high specificity to tumour, ctDNA is regarded as an effective yet non-invasive cancer biomarker. ctDNA technology could discover the presence of mutation before it develops into malignant tumours

Allergy Tests
Suitable for
Anyone with allergic symptoms such as hives, skin rash, nasal congestion, runny nose, itchy eyes, etc
Turn around time
2 weeks
Specimen
3ml blood
Specification

Measure the presence of IgE antibodies in the blood. Detect 52 different types of enviornmental allergens and 54 different types of food allergens

HPV DNA Self Collection Test
Suitable for
Any sexually active female
Turn around time
5 days
Specimen
Vaginal swab
Specification

Test over 33 types of HPV DNA

DNA Talent Test
Suitable for
Age 0-12 years old
Turn around time
21 days
Specimen
Buccal swab/saliva
Specification

Based on the results from the GWAS (Genome-Wide Association Study). This talent test will unlock the full scale of your child's physical, mental and intellectual potential. Understanding these will help establish targeted child-rearing methods and lay a solid foundation for your child's development

Maternal Blood Y-DNA Rapid Test
Suitable for
In order to protect clients' best interest and to ensure a test accuracy of 99.9%, this test requires gestational age of 7 weeks or above subject to ultrasound examination(CRL>10mm)
Turn around time
One day
Specimen
12 ml blood
Specification

If client completes blood draw at the clinic before 12pm, they will receive an e-report via email before 7 pm. The accuracy of this test is 99.9%

Hereditary Risk Assessment - Kids Panel
Suitable for
Any kids
Turn around time
6 weeks
Specimen
6ml blood or 6 buccal swabs
Specification

Screen over 90 genes for 10 most common diseases during childhood

Prenatal Parentage Test - Maternal Blood (MBY)
Suitable for
7 weeks pregnant or above
Turn around time
6 days
Specimen
18ml blood
Specification

Non-invasive prenatal parentage blood test

Prenatal Parentage Test - Paternal Blood
Suitable for
7 weeks gestation or above (for male fetus)
Turn around time
6 days
Specimen
6ml blood
Specification

Need to perform MBY test first. Compares the DNA of the child within maternal blood with the alleged father to determine if half of the DNA between them is identical

DNA Diagnostic Center Non-invasive Prenatal Paternity Test
Suitable for
10 weeks gestation or above (for female fetus)
Turn around time
10 days
Specimen
20ml blood
Specification

DNA profile of the baby is determined from free-floating fetal cells found in the mother's blood sample. The baby’s profile is compared to the DNA profile of the man tested

Postnatal Parentage Tests
Suitable for
From newborn to adult
Turn around time
5 days
Specimen
6ml blood or 4 buccal swabs
Specification

Postnatal Parentage Tests report can be used for private or legal purpose, such as for immigration

HPV Antibody Test (Upgrade)
Suitable for
People who are vaccinated against HPV
Turn around time
5 working days
Specimen
3ml clotted-blood
Specification

Designed for people who are vaccinated against HPV

The latest HPV antibody test covers all antibodies of the nine-valent HPV vaccine, including HPV6,11,16,18,31,33,45,52,58

According to the degree of antibody-antigen binding, you can accurately determine the level of 9 antibodies through quantitative experiments